<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2004-06-07" modified="2017-04-12" version="145">
<accession>Q7Z333</accession>
<accession>A2A396</accession>
<accession>B2RPB2</accession>
<accession>B5ME16</accession>
<accession>C9JQ10</accession>
<accession>O75120</accession>
<accession>Q3KQX4</accession>
<accession>Q5JUJ1</accession>
<accession>Q68DW5</accession>
<accession>Q6AZD7</accession>
<accession>Q7Z3J6</accession>
<accession>Q8WX33</accession>
<accession>Q9H9D1</accession>
<accession>Q9NVP9</accession>
<name>SETX_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="36">Probable helicase senataxin</fullName>
<ecNumber>3.6.4.-</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Amyotrophic lateral sclerosis 4 protein</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="36">SEN1 homolog</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="34 37">Senataxin</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="34 37">SETX</name>
<name type="synonym">ALS4</name>
<name type="synonym">KIAA0625</name>
<name type="synonym">SCAR1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="225" last="227">
<title>Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2.</title>
<authorList>
<person name="Moreira M.-C."/>
<person name="Klur S."/>
<person name="Watanabe M."/>
<person name="Nemeth A.H."/>
<person name="Le Ber I."/>
<person name="Moniz J.-C."/>
<person name="Tranchant C."/>
<person name="Aubourg P."/>
<person name="Tazir M."/>
<person name="Schoels L."/>
<person name="Pandolfo M."/>
<person name="Schulz J.B."/>
<person name="Pouget J."/>
<person name="Calvas P."/>
<person name="Shizuka-Ikeda M."/>
<person name="Shoji M."/>
<person name="Tanaka M."/>
<person name="Izatt L."/>
<person name="Shaw C.E."/>
<person name="M'Zahem A."/>
<person name="Dunne E."/>
<person name="Bomont P."/>
<person name="Benhassine T."/>
<person name="Bouslam N."/>
<person name="Stevanin G."/>
<person name="Brice A."/>
<person name="Guimaraes J."/>
<person name="Mendonca P."/>
<person name="Barbot C."/>
<person name="Coutinho P."/>
<person name="Sequeiros J."/>
<person name="Duerr A."/>
<person name="Warter J.-M."/>
<person name="Koenig M."/>
</authorList>
<dbReference type="PubMed" id="14770181"/>
<dbReference type="DOI" id="10.1038/ng1303"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANT CYS-1152</scope>
<scope>VARIANTS SCAR1 CYS-305; TRP-332; LEU-413; SER-1756 AND LEU-2213</scope>
<scope>INVOLVEMENT IN ALS4</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 447-2677 (ISOFORM 3)</scope>
<scope>VARIANTS GLU-1192; ARG-1252; VAL-1386 AND VAL-2587</scope>
<source>
<tissue>Amygdala</tissue>
<tissue>Fetal kidney</tissue>
<tissue>Retina</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nature" volume="429" first="369" last="374">
<title>DNA sequence and analysis of human chromosome 9.</title>
<authorList>
<person name="Humphray S.J."/>
<person name="Oliver K."/>
<person name="Hunt A.R."/>
<person name="Plumb R.W."/>
<person name="Loveland J.E."/>
<person name="Howe K.L."/>
<person name="Andrews T.D."/>
<person name="Searle S."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Jones M.C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Babbage S."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Chen Y."/>
<person name="Clarke G."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Crosier M."/>
<person name="Cummings A.T."/>
<person name="Davies J."/>
<person name="Dhami P."/>
<person name="Dunn M."/>
<person name="Dutta I."/>
<person name="Dyer L.W."/>
<person name="Earthrowl M.E."/>
<person name="Faulkner L."/>
<person name="Fleming C.J."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="French L."/>
<person name="Fricker D.G."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori J."/>
<person name="Gilbert J.G.R."/>
<person name="Glison C."/>
<person name="Grafham D.V."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Guy J."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Harrison E.S.I."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Henderson C.D."/>
<person name="Hopkins B.L."/>
<person name="Howard P.J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S."/>
<person name="Kershaw J.K."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nisbett J."/>
<person name="Nordsiek G."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Porter K.M."/>
<person name="Pandian R."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Povey S."/>
<person name="Ramsey Y."/>
<person name="Rand V."/>
<person name="Scharfe M."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S.K."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C.A."/>
<person name="Swarbreck D."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Thomas D.W."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="Whitehead S.L."/>
<person name="Willey D.L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Ashurst J.L."/>
<person name="Coulson A."/>
<person name="Blocker H."/>
<person name="Durbin R.M."/>
<person name="Sulston J.E."/>
<person name="Hubbard T."/>
<person name="Jackson M.J."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Dunham I."/>
</authorList>
<dbReference type="PubMed" id="15164053"/>
<dbReference type="DOI" id="10.1038/nature02465"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANTS GLU-1192; ARG-1252; VAL-1386; ALA-1855; VAL-2587 AND GLY-2612</scope>
<source>
<tissue>Peripheral nerve</tissue>
<tissue>Retinoblastoma</tissue>
<tissue>Testis</tissue>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1998" name="DNA Res." volume="5" first="169" last="176">
<title>Prediction of the coding sequences of unidentified human genes. X. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.</title>
<authorList>
<person name="Ishikawa K."/>
<person name="Nagase T."/>
<person name="Suyama M."/>
<person name="Miyajima N."/>
<person name="Tanaka A."/>
<person name="Kotani H."/>
<person name="Nomura N."/>
<person name="Ohara O."/>
</authorList>
<dbReference type="PubMed" id="9734811"/>
<dbReference type="DOI" id="10.1093/dnares/5.3.169"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 15-2677 (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1762-2677 (ISOFORM 1)</scope>
<scope>VARIANT VAL-2587</scope>
<source>
<tissue>Teratocarcinoma</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1017 AND SER-1019</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1621</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2007" name="J. Cell Biol." volume="177" first="969" last="979">
<title>Senataxin, defective in ataxia oculomotor apraxia type 2, is involved in the defense against oxidative DNA damage.</title>
<authorList>
<person name="Suraweera A."/>
<person name="Becherel O.J."/>
<person name="Chen P."/>
<person name="Rundle N."/>
<person name="Woods R."/>
<person name="Nakamura J."/>
<person name="Gatei M."/>
<person name="Criscuolo C."/>
<person name="Filla A."/>
<person name="Chessa L."/>
<person name="Fusser M."/>
<person name="Epe B."/>
<person name="Gueven N."/>
<person name="Lavin M.F."/>
</authorList>
<dbReference type="PubMed" id="17562789"/>
<dbReference type="DOI" id="10.1083/jcb.200701042"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-615; SER-1017 AND SER-1019</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2009" name="Hum. Mol. Genet." volume="18" first="3384" last="3396">
<title>Functional role for senataxin, defective in ataxia oculomotor apraxia type 2, in transcriptional regulation.</title>
<authorList>
<person name="Suraweera A."/>
<person name="Lim Y."/>
<person name="Woods R."/>
<person name="Birrell G.W."/>
<person name="Nasim T."/>
<person name="Becherel O.J."/>
<person name="Lavin M.F."/>
</authorList>
<dbReference type="PubMed" id="19515850"/>
<dbReference type="DOI" id="10.1093/hmg/ddp278"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NCL; PABPN1; PABPC1; POLR2A; SF3B1 AND SMN1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1017</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1017 AND SER-1019</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2011" name="Brain" volume="134" first="1808" last="1828">
<title>Senataxin modulates neurite growth through fibroblast growth factor 8 signalling.</title>
<authorList>
<person name="Vantaggiato C."/>
<person name="Bondioni S."/>
<person name="Airoldi G."/>
<person name="Bozzato A."/>
<person name="Borsani G."/>
<person name="Rugarli E.I."/>
<person name="Bresolin N."/>
<person name="Clementi E."/>
<person name="Bassi M.T."/>
</authorList>
<dbReference type="PubMed" id="21576111"/>
<dbReference type="DOI" id="10.1093/brain/awr084"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2011" name="DNA Repair" volume="10" first="199" last="209">
<title>Role of senataxin in DNA damage and telomeric stability.</title>
<authorList>
<person name="De Amicis A."/>
<person name="Piane M."/>
<person name="Ferrari F."/>
<person name="Fanciulli M."/>
<person name="Delia D."/>
<person name="Chessa L."/>
</authorList>
<dbReference type="PubMed" id="21112256"/>
<dbReference type="DOI" id="10.1016/j.dnarep.2010.10.012"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2011" name="Mol. Cell" volume="42" first="794" last="805">
<title>Human senataxin resolves RNA/DNA hybrids formed at transcriptional pause sites to promote Xrn2-dependent termination.</title>
<authorList>
<person name="Skourti-Stathaki K."/>
<person name="Proudfoot N.J."/>
<person name="Gromak N."/>
</authorList>
<dbReference type="PubMed" id="21700224"/>
<dbReference type="DOI" id="10.1016/j.molcel.2011.04.026"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1017 AND SER-1019</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2013" name="Genes Dev." volume="27" first="2227" last="2232">
<title>A SUMO-dependent interaction between Senataxin and the exosome, disrupted in the neurodegenerative disease AOA2, targets the exosome to sites of transcription-induced DNA damage.</title>
<authorList>
<person name="Richard P."/>
<person name="Feng S."/>
<person name="Manley J.L."/>
</authorList>
<dbReference type="PubMed" id="24105744"/>
<dbReference type="DOI" id="10.1101/gad.224923.113"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH EXOSC9 AND UBE2I</scope>
<scope>SUMOYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHARACTERIZATION OF VARIANTS SCAR1 CYS-305 AND LEU-413</scope>
<scope>CHARACTERIZATION OF VARIANTS ALS4 ILE-3 AND SER-389</scope>
<scope>MUTAGENESIS OF GLU-65</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-642; SER-911; SER-947; SER-956; SER-1330; SER-1366; SER-1623; SER-1663 AND THR-2474</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2013" name="Mol. Cell. Biol." volume="33" first="406" last="417">
<title>Senataxin, defective in the neurodegenerative disorder ataxia with oculomotor apraxia 2, lies at the interface of transcription and the DNA damage response.</title>
<authorList>
<person name="Yuce O."/>
<person name="West S.C."/>
</authorList>
<dbReference type="PubMed" id="23149945"/>
<dbReference type="DOI" id="10.1128/MCB.01195-12"/>
</citation>
<scope>INTERACTION WITH CHD4; POLR2A; PRKDC AND TRIM28</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1017 AND SER-1019</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-339</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.O114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1063</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2016" name="Nature" volume="529" first="48" last="53">
<title>SMN and symmetric arginine dimethylation of RNA polymerase II C-terminal domain control termination.</title>
<authorList>
<person name="Yanling Zhao D."/>
<person name="Gish G."/>
<person name="Braunschweig U."/>
<person name="Li Y."/>
<person name="Ni Z."/>
<person name="Schmitges F.W."/>
<person name="Zhong G."/>
<person name="Liu K."/>
<person name="Li W."/>
<person name="Moffat J."/>
<person name="Vedadi M."/>
<person name="Min J."/>
<person name="Pawson T.J."/>
<person name="Blencowe B.J."/>
<person name="Greenblatt J.F."/>
</authorList>
<dbReference type="PubMed" id="26700805"/>
<dbReference type="DOI" id="10.1038/nature16469"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH POLR2A AND SMN1</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2004" name="Am. J. Hum. Genet." volume="74" first="1128" last="1135">
<title>DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4).</title>
<authorList>
<person name="Chen Y.-Z."/>
<person name="Bennett C.L."/>
<person name="Huynh H.M."/>
<person name="Blair I.P."/>
<person name="Puls I."/>
<person name="Irobi J."/>
<person name="Dierick I."/>
<person name="Abel A."/>
<person name="Kennerson M.L."/>
<person name="Rabin B.A."/>
<person name="Nicholson G.A."/>
<person name="Auer-Grumbach M."/>
<person name="Wagner K."/>
<person name="De Jonghe P."/>
<person name="Griffin J.W."/>
<person name="Fischbeck K.H."/>
<person name="Timmerman V."/>
<person name="Cornblath D.R."/>
<person name="Chance P.F."/>
</authorList>
<dbReference type="PubMed" id="15106121"/>
<dbReference type="DOI" id="10.1086/421054"/>
</citation>
<scope>VARIANTS ALS4 SER-389 AND HIS-2136</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2006" name="Neurobiol. Dis." volume="23" first="97" last="108">
<title>Senataxin, the yeast Sen1p orthologue: characterization of a unique protein in which recessive mutations cause ataxia and dominant mutations cause motor neuron disease.</title>
<authorList>
<person name="Chen Y.-Z."/>
<person name="Hashemi S.H."/>
<person name="Anderson S.K."/>
<person name="Huang Y."/>
<person name="Moreira M.-C."/>
<person name="Lynch D.R."/>
<person name="Glass I.A."/>
<person name="Chance P.F."/>
<person name="Bennett C.L."/>
</authorList>
<dbReference type="PubMed" id="16644229"/>
<dbReference type="DOI" id="10.1016/j.nbd.2006.02.007"/>
</citation>
<scope>VARIANT SCAR1 ARG-2368</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2006" name="Neurology" volume="66" first="1580" last="1581">
<title>Autosomal recessive ataxia with peripheral neuropathy and elevated AFP: novel mutations in SETX.</title>
<authorList>
<person name="Asaka T."/>
<person name="Yokoji H."/>
<person name="Ito J."/>
<person name="Yamaguchi K."/>
<person name="Matsushima A."/>
</authorList>
<dbReference type="PubMed" id="16717225"/>
<dbReference type="DOI" id="10.1212/01.wnl.0000216135.59699.9b"/>
</citation>
<scope>VARIANTS SCAR1 ILE-274 AND CYS-1294</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2007" name="Neurogenetics" volume="8" first="45" last="49">
<title>In cis autosomal dominant mutation of Senataxin associated with tremor/ataxia syndrome.</title>
<authorList>
<person name="Bassuk A.G."/>
<person name="Chen Y.Z."/>
<person name="Batish S.D."/>
<person name="Nagan N."/>
<person name="Opal P."/>
<person name="Chance P.F."/>
<person name="Bennett C.L."/>
</authorList>
<dbReference type="PubMed" id="17096168"/>
<dbReference type="DOI" id="10.1007/s10048-006-0067-8"/>
</citation>
<scope>VARIANTS SCAR1 ASP-603 AND LYS-653</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2011" name="Amyotroph. Lateral Scler." volume="12" first="223" last="227">
<title>Senataxin mutations and amyotrophic lateral sclerosis.</title>
<authorList>
<person name="Hirano M."/>
<person name="Quinzii C.M."/>
<person name="Mitsumoto H."/>
<person name="Hays A.P."/>
<person name="Roberts J.K."/>
<person name="Richard P."/>
<person name="Rowland L.P."/>
</authorList>
<dbReference type="PubMed" id="21190393"/>
<dbReference type="DOI" id="10.3109/17482968.2010.545952"/>
</citation>
<scope>VARIANTS ALS4 GLY-1554; GLU-2029 AND THR-2547</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2013" name="Int. J. Neurosci." volume="123" first="670" last="673">
<title>A new SETX mutation producing AOA2 in two siblings.</title>
<authorList>
<person name="Datta N."/>
<person name="Hohler A."/>
</authorList>
<dbReference type="PubMed" id="23566282"/>
<dbReference type="DOI" id="10.3109/00207454.2013.787616"/>
</citation>
<scope>VARIANTS SCAR1 VAL-274 AND ARG-1976</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2013" name="J. Neurol. Sci." volume="331" first="158" last="160">
<title>Exome analysis reveals a Japanese family with spinocerebellar ataxia, autosomal recessive 1.</title>
<authorList>
<person name="Ichikawa Y."/>
<person name="Ishiura H."/>
<person name="Mitsui J."/>
<person name="Takahashi Y."/>
<person name="Kobayashi S."/>
<person name="Takuma H."/>
<person name="Kanazawa I."/>
<person name="Doi K."/>
<person name="Yoshimura J."/>
<person name="Morishita S."/>
<person name="Goto J."/>
<person name="Tsuji S."/>
</authorList>
<dbReference type="PubMed" id="23786967"/>
<dbReference type="DOI" id="10.1016/j.jns.2013.05.018"/>
</citation>
<scope>INVOLVEMENT IN SCAR1</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2013" name="Orphanet J. Rare Dis." volume="8" first="123" last="123">
<title>SETX mutations are a frequent genetic cause of juvenile and adult onset cerebellar ataxia with neuropathy and elevated serum alpha-fetoprotein.</title>
<authorList>
<person name="Nanetti L."/>
<person name="Cavalieri S."/>
<person name="Pensato V."/>
<person name="Erbetta A."/>
<person name="Pareyson D."/>
<person name="Panzeri M."/>
<person name="Zorzi G."/>
<person name="Antozzi C."/>
<person name="Moroni I."/>
<person name="Gellera C."/>
<person name="Brusco A."/>
<person name="Mariotti C."/>
</authorList>
<dbReference type="PubMed" id="23941260"/>
<dbReference type="DOI" id="10.1186/1750-1172-8-123"/>
</citation>
<scope>VARIANTS SCAR1 LYS-331; LEU-496 AND THR-2229</scope>
<scope>VARIANT ARG-992</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2013" name="PLoS ONE" volume="8" first="E78837" last="E78837">
<title>Protein interaction analysis of senataxin and the ALS4 L389S mutant yields insights into senataxin post-translational modification and uncovers mutant-specific binding with a brain cytoplasmic RNA-encoded peptide.</title>
<authorList>
<person name="Bennett C.L."/>
<person name="Chen Y."/>
<person name="Vignali M."/>
<person name="Lo R.S."/>
<person name="Mason A.G."/>
<person name="Unal A."/>
<person name="Huq Saifee N.P."/>
<person name="Fields S."/>
<person name="La Spada A.R."/>
</authorList>
<dbReference type="PubMed" id="24244371"/>
<dbReference type="DOI" id="10.1371/journal.pone.0078837"/>
</citation>
<scope>VARIANT SER-389</scope>
<scope>CHARACTERIZATION OF VARIANT ALS4 SER-389</scope>
<scope>SUBUNIT</scope>
<scope>LACK OF INTERACTION WITH C14ORF178</scope>
<scope>UBIQUITINATION</scope>
<scope>SUMOYLATION</scope>
</reference>
<comment type="function">
<text evidence="11 20 22 23 25 26 31 33">Probable RNA/DNA helicase involved in diverse aspects of RNA metabolism and genomic integrity. Plays a role in transcription regulation by its ability to modulate RNA Polymerase II (Pol II) binding to chromatin and through its interaction with proteins involved in transcription (PubMed:19515850, PubMed:21700224). Contributes to the mRNA splicing efficiency and splice site selection (PubMed:19515850). Required for the resolution of R-loop RNA-DNA hybrid formation at G-rich pause sites located downstream of the poly(A) site, allowing XRN2 recruitment and XRN2-mediated degradation of the downstream cleaved RNA and hence efficient RNA polymerase II (RNAp II) transcription termination (PubMed:19515850, PubMed:21700224, PubMed:26700805). Required for the 3' transcriptional termination of PER1 and CRY2, thus playing an important role in the circadian rhythm regulation (By similarity). Involved in DNA double-strand breaks damage response generated by oxidative stress (PubMed:17562789). In association with RRP45, targets the RNA exosome complex to sites of transcription-induced DNA damage (PubMed:24105744). Plays a role in the development and maturation of germ cells: essential for male meiosis, acting at the interface of transcription and meiotic recombination, and in the process of gene silencing during meiotic sex chromosome inactivation (MSCI) (By similarity). May be involved in telomeric stability through the regulation of telomere repeat-containing RNA (TERRA) transcription (PubMed:21112256). Plays a role in neurite outgrowth in hippocampal cells through FGF8-activated signaling pathways. Inhibits retinoic acid-induced apoptosis (PubMed:21576111).</text>
</comment>
<comment type="subunit">
<text evidence="11 22 27 31 32 33">Homodimer (PubMed:24244371). Interacts with PER2; the interaction inhibits termination of circadian target genes (By similarity). Interacts with CHD4, POLR2A, PRKDC and TRIM28 (PubMed:23149945). Does not interact with C14orf178 (PubMed:24244371). Interacts with UBE2I (PubMed:24105744). Interacts (via N-terminus domain) with EXOSC9 (via C-terminus region); the interaction enhances SETX sumoylation (PubMed:24105744). Interacts with NCL (via N-terminus domain) (PubMed:19515850). Interacts with PABPN1, PABPC1 and SF3B1 (PubMed:19515850). Interacts with SMN1/SMN2 and POLR2A; SMN1/SMN2 recruits SETX to POLR2A (PubMed:19515850, PubMed:26700805).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1220123"/>
<interactant intactId="EBI-1220123"/>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1220123"/>
<interactant intactId="EBI-80168">
<id>P63279</id>
<label>UBE2I</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="20 25 31">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="20">Nucleus</location>
<location evidence="20">Nucleoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="20">Nucleus</location>
<location evidence="20">Nucleolus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="20 25">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="27">Chromosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="23">Chromosome</location>
<location evidence="23">Telomere</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="25">Cell projection</location>
<location evidence="25">Axon</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="25">Cell projection</location>
<location evidence="25">Growth cone</location>
</subcellularLocation>
<text evidence="11 20 23 25 27 31">May be detected in the nucleolus only in cycling cells. At pachytene stage, colocalizes predominantly to the heterochromatic XY-body of sex chromosomes with DNA damage response proteins in a BRCA1-dependent manner (By similarity). Localizes with telomeric DNA in a transcription-dependent manner (PubMed:21112256). Under replication stress, colocalizes with a variety of DNA damage signaling and repair response proteins at distinct nuclear foci in mitotic S/G2- and G1-phase cells in a transcription- and RNA/DNA hybrid-dependent manner (PubMed:23149945). Localizes at limited number of nuclear foci (PubMed:24105744). Colocalizes with EXOSC9 in nuclear foci upon induction of transcription-related DNA damage at the S phase (PubMed:24105744). Most abundant in the nucleus. Detected in granules. Colocalized in cycling cells with FBL in the nucleolus.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q7Z333-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q7Z333-3</id>
<name>3</name>
<sequence type="described" ref="VSP_017124"/>
<text>No experimental confirmation available.</text>
</isoform>
<isoform>
<id>Q7Z333-4</id>
<name>4</name>
<sequence type="described" ref="VSP_028826"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="14 15 17 20">Highly expressed in skeletal muscle. Expressed in heart, fibroblast, placenta and liver. Weakly expressed in brain and lung. Expressed in the cortex of the kidney (highly expressed in tubular epithelial cells but low expression in the glomerulus).</text>
</comment>
<comment type="domain">
<text evidence="27">The N-terminus domain is necessary for S/G2 nuclear foci localization (PubMed:23149945).</text>
</comment>
<comment type="PTM">
<text evidence="32">Ubiquitinated.</text>
</comment>
<comment type="PTM">
<text evidence="31 32">Sumoylated preferentially with SUMO2 or SUMO3 (PubMed:24105744, PubMed:24244371).</text>
</comment>
<comment type="disease" evidence="14 17 18 19 28 29 30 31">
<disease id="DI-01061">
<name>Spinocerebellar ataxia, autosomal recessive, 1</name>
<acronym>SCAR1</acronym>
<description>Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR1 is an autosomal recessive form associated with peripheral neuropathy and elevated serum alpha-fetoprotein, immunoglobulins and, less commonly, creatine kinase levels. Some SCAR1 patients manifest oculomotor apraxia.</description>
<dbReference type="MIM" id="606002"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="14 15 24 31 32">
<disease id="DI-00110">
<name>Amyotrophic lateral sclerosis 4</name>
<acronym>ALS4</acronym>
<description>A form of amyotrophic lateral sclerosis with childhood- or adolescent-onset, and characterized by slow disease progression and the sparing of bulbar and respiratory muscles. Amyotrophic lateral sclerosis is a neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases.</description>
<dbReference type="MIM" id="602433"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="36">Belongs to the DNA2/NAM7 helicase family.</text>
</comment>
<comment type="sequence caution" evidence="36">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAA91701" version="1"/>
</conflict>
<text>Translation N-terminally extended.</text>
</comment>
<comment type="sequence caution" evidence="36">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAB14299" version="1"/>
</conflict>
<text>Translation N-terminally extended.</text>
</comment>
<comment type="sequence caution" evidence="36">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="CAD97857" version="1"/>
</conflict>
<location>
<position position="1626"/>
</location>
</comment>
<dbReference type="EC" id="3.6.4.-"/>
<dbReference type="EMBL" id="AY362728">
<property type="protein sequence ID" value="AAR13367.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BX537849">
<property type="protein sequence ID" value="CAD97857.1"/>
<property type="status" value="ALT_FRAME"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BX538166">
<property type="protein sequence ID" value="CAD98045.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR749249">
<property type="protein sequence ID" value="CAH18105.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL159997">
<property type="protein sequence ID" value="CAI40854.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL353701">
<property type="protein sequence ID" value="CAI40854.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL159997">
<property type="protein sequence ID" value="CAI40857.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL353701">
<property type="protein sequence ID" value="CAM14151.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL159997">
<property type="protein sequence ID" value="CAM14151.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC032600">
<property type="protein sequence ID" value="AAH32600.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC032622">
<property type="protein sequence ID" value="AAH32622.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC078166">
<property type="protein sequence ID" value="AAH78166.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC106017">
<property type="protein sequence ID" value="AAI06018.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC137350">
<property type="protein sequence ID" value="AAI37351.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB014525">
<property type="protein sequence ID" value="BAA31600.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK001456">
<property type="protein sequence ID" value="BAA91701.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK022902">
<property type="protein sequence ID" value="BAB14299.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6947.1">
<molecule id="Q7Z333-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_055861.3">
<molecule id="Q7Z333-1"/>
<property type="nucleotide sequence ID" value="NM_015046.5"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005272228.1">
<molecule id="Q7Z333-4"/>
<property type="nucleotide sequence ID" value="XM_005272171.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005272229.1">
<molecule id="Q7Z333-4"/>
<property type="nucleotide sequence ID" value="XM_005272172.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005272230.1">
<molecule id="Q7Z333-4"/>
<property type="nucleotide sequence ID" value="XM_005272173.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011516706.1">
<molecule id="Q7Z333-4"/>
<property type="nucleotide sequence ID" value="XM_011518404.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011516707.1">
<molecule id="Q7Z333-4"/>
<property type="nucleotide sequence ID" value="XM_011518405.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016869984.1">
<molecule id="Q7Z333-1"/>
<property type="nucleotide sequence ID" value="XM_017014495.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016869986.1">
<property type="nucleotide sequence ID" value="XM_017014497.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.460317"/>
<dbReference type="ProteinModelPortal" id="Q7Z333"/>
<dbReference type="BioGrid" id="116699">
<property type="interactions" value="41"/>
</dbReference>
<dbReference type="DIP" id="DIP-38360N"/>
<dbReference type="IntAct" id="Q7Z333">
<property type="interactions" value="29"/>
</dbReference>
<dbReference type="MINT" id="MINT-4649968"/>
<dbReference type="STRING" id="9606.ENSP00000224140"/>
<dbReference type="iPTMnet" id="Q7Z333"/>
<dbReference type="PhosphoSitePlus" id="Q7Z333"/>
<dbReference type="BioMuta" id="SETX"/>
<dbReference type="DMDM" id="296453021"/>
<dbReference type="EPD" id="Q7Z333"/>
<dbReference type="MaxQB" id="Q7Z333"/>
<dbReference type="PaxDb" id="Q7Z333"/>
<dbReference type="PeptideAtlas" id="Q7Z333"/>
<dbReference type="PRIDE" id="Q7Z333"/>
<dbReference type="Ensembl" id="ENST00000224140">
<molecule id="Q7Z333-1"/>
<property type="protein sequence ID" value="ENSP00000224140"/>
<property type="gene ID" value="ENSG00000107290"/>
</dbReference>
<dbReference type="GeneID" id="23064"/>
<dbReference type="KEGG" id="hsa:23064"/>
<dbReference type="UCSC" id="uc004cbk.4">
<molecule id="Q7Z333-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="23064"/>
<dbReference type="DisGeNET" id="23064"/>
<dbReference type="GeneCards" id="SETX"/>
<dbReference type="GeneReviews" id="SETX"/>
<dbReference type="HGNC" id="HGNC:445">
<property type="gene designation" value="SETX"/>
</dbReference>
<dbReference type="HPA" id="HPA024105"/>
<dbReference type="HPA" id="HPA057269"/>
<dbReference type="MalaCards" id="SETX"/>
<dbReference type="MIM" id="602433">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="606002">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="608465">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q7Z333"/>
<dbReference type="OpenTargets" id="ENSG00000107290"/>
<dbReference type="Orphanet" id="357043">
<property type="disease" value="Amyotrophic lateral sclerosis type 4"/>
</dbReference>
<dbReference type="Orphanet" id="64753">
<property type="disease" value="Spinocerebellar ataxia with axonal neuropathy type 2"/>
</dbReference>
<dbReference type="PharmGKB" id="PA24751"/>
<dbReference type="eggNOG" id="KOG1801">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG1112">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00810000125415"/>
<dbReference type="HOVERGEN" id="HBG108476"/>
<dbReference type="InParanoid" id="Q7Z333"/>
<dbReference type="KO" id="K10706"/>
<dbReference type="OMA" id="PEDMDLC"/>
<dbReference type="OrthoDB" id="EOG091G01EA"/>
<dbReference type="PhylomeDB" id="Q7Z333"/>
<dbReference type="TreeFam" id="TF324634"/>
<dbReference type="ChiTaRS" id="SETX">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="SETX"/>
<dbReference type="GenomeRNAi" id="23064"/>
<dbReference type="PRO" id="PR:Q7Z333"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 9"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000107290"/>
<dbReference type="ExpressionAtlas" id="Q7Z333">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q7Z333">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0030424">
<property type="term" value="C:axon"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000781">
<property type="term" value="C:chromosome, telomeric region"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030426">
<property type="term" value="C:growth cone"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045171">
<property type="term" value="C:intercellular bridge"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0016604">
<property type="term" value="C:nuclear body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0000228">
<property type="term" value="C:nuclear chromosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003678">
<property type="term" value="F:DNA helicase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0001147">
<property type="term" value="F:transcription termination site sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044344">
<property type="term" value="P:cellular response to fibroblast growth factor stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070301">
<property type="term" value="P:cellular response to hydrogen peroxide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034599">
<property type="term" value="P:cellular response to oxidative stress"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071300">
<property type="term" value="P:cellular response to retinoic acid"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007623">
<property type="term" value="P:circadian rhythm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006310">
<property type="term" value="P:DNA recombination"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006353">
<property type="term" value="P:DNA-templated transcription, termination"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006302">
<property type="term" value="P:double-strand break repair"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008543">
<property type="term" value="P:fibroblast growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006376">
<property type="term" value="P:mRNA splice site selection"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000144">
<property type="term" value="P:positive regulation of DNA-templated transcription, initiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060566">
<property type="term" value="P:positive regulation of DNA-templated transcription, termination"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010976">
<property type="term" value="P:positive regulation of neuron projection development"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033120">
<property type="term" value="P:positive regulation of RNA splicing"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000806">
<property type="term" value="P:positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043491">
<property type="term" value="P:protein kinase B signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006396">
<property type="term" value="P:RNA processing"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007283">
<property type="term" value="P:spermatogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006369">
<property type="term" value="P:termination of RNA polymerase II transcription"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="InterPro" id="IPR027417">
<property type="entry name" value="P-loop_NTPase"/>
</dbReference>
<dbReference type="InterPro" id="IPR026121">
<property type="entry name" value="Senataxin"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10887:SF381">
<property type="entry name" value="PTHR10887:SF381"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52540">
<property type="entry name" value="SSF52540"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0036">Amyotrophic lateral sclerosis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0090">Biological rhythms</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0158">Chromosome</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0233">DNA recombination</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0347">Helicase</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0524">Neurogenesis</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0744">Spermatogenesis</keyword>
<keyword id="KW-0779">Telomere</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Probable helicase senataxin" id="PRO_0000080724">
<location>
<begin position="1"/>
<end position="2677"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="12">
<location>
<begin position="1963"/>
<end position="1970"/>
</location>
</feature>
<feature type="region of interest" description="Necessary for nuclear localization">
<location>
<begin position="2661"/>
<end position="2677"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="12">
<location>
<begin position="2105"/>
<end position="2136"/>
</location>
</feature>
<feature type="short sequence motif" description="Bipartite nuclear localization signal" evidence="12">
<location>
<begin position="2070"/>
<end position="2087"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="615"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="642"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="878"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="911"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="947"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="956"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 3 4 5 6 8">
<location>
<position position="1017"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 3 5 6 8">
<location>
<position position="1019"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="1330"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="1366"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="1489"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="1621"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="1623"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="1663"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="7">
<location>
<position position="2474"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)" evidence="9">
<location>
<position position="339"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="10">
<location>
<position position="1063"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_017124" evidence="35">
<location>
<begin position="2367"/>
<end position="2399"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_028826" evidence="36">
<original>M</original>
<variation>MQLLPRSFCVHVNHSPFFSPEPKYLHWALK</variation>
<location>
<position position="2429"/>
</location>
</feature>
<feature type="sequence variant" description="In ALS4; heterozygous; does not affect the interaction with EXOSC9 and UBE2I; does not decrease sumoylation; dbSNP:rs28941475." id="VAR_018776" evidence="31">
<original>T</original>
<variation>I</variation>
<location>
<position position="3"/>
</location>
</feature>
<feature type="sequence variant" description="In SCAR1." id="VAR_036646" evidence="18">
<original>M</original>
<variation>I</variation>
<location>
<position position="274"/>
</location>
</feature>
<feature type="sequence variant" description="In SCAR1; dbSNP:rs753713810." id="VAR_072587" evidence="28">
<original>M</original>
<variation>V</variation>
<location>
<position position="274"/>
</location>
</feature>
<feature type="sequence variant" description="In SCAR1; abolishes interaction with EXOSC9; does not abolish interaction with UBE2I; decreases sumoylation." id="VAR_018777" evidence="14 31">
<original>W</original>
<variation>C</variation>
<location>
<position position="305"/>
</location>
</feature>
<feature type="sequence variant" description="In SCAR1." id="VAR_071682" evidence="30">
<original>I</original>
<variation>K</variation>
<location>
<position position="331"/>
</location>
</feature>
<feature type="sequence variant" description="In SCAR1; dbSNP:rs29001665." id="VAR_018778" evidence="14">
<original>R</original>
<variation>W</variation>
<location>
<position position="332"/>
</location>
</feature>
<feature type="sequence variant" description="In ALS4; does not affect the interaction with EXOSC9 and UBE2I; does not decrease sumoylation and ubiquitination; does not inhibit homodimerization; unlike the wild-type protein the mutant induces interaction with C14orf178; dbSNP:rs29001584." id="VAR_018779" evidence="15 31 32">
<original>L</original>
<variation>S</variation>
<location>
<position position="389"/>
</location>
</feature>
<feature type="sequence variant" description="In SCAR1; abolishes interaction with EXOSC9; does not abolish interaction with UBE2I; decreases sumoylation." id="VAR_018780" evidence="14 31">
<original>P</original>
<variation>L</variation>
<location>
<position position="413"/>
</location>
</feature>
<feature type="sequence variant" description="In SCAR1." id="VAR_071683" evidence="30">
<original>P</original>
<variation>L</variation>
<location>
<position position="496"/>
</location>
</feature>
<feature type="sequence variant" description="In SCAR1; atypical; associated with K-653; dbSNP:rs116205032." id="VAR_036647" evidence="19">
<original>N</original>
<variation>D</variation>
<location>
<position position="603"/>
</location>
</feature>
<feature type="sequence variant" description="In SCAR1; atypical; associated with D-603; dbSNP:rs116333061." id="VAR_036648" evidence="19">
<original>Q</original>
<variation>K</variation>
<location>
<position position="653"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs882709." id="VAR_018781">
<original>A</original>
<variation>G</variation>
<location>
<position position="660"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs61742937." id="VAR_071684" evidence="30">
<original>K</original>
<variation>R</variation>
<location>
<position position="992"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs12352982." id="VAR_018782">
<original>P</original>
<variation>L</variation>
<location>
<position position="1061"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3739922." id="VAR_018783" evidence="14">
<original>F</original>
<variation>C</variation>
<location>
<position position="1152"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1185193." id="VAR_018784" evidence="16 21">
<original>D</original>
<variation>E</variation>
<location>
<position position="1192"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs12344006." id="VAR_056208">
<original>K</original>
<variation>N</variation>
<location>
<position position="1221"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1183768." id="VAR_018785" evidence="16 21">
<original>G</original>
<variation>R</variation>
<location>
<position position="1252"/>
</location>
</feature>
<feature type="sequence variant" description="In SCAR1; dbSNP:rs267607044." id="VAR_036649" evidence="18">
<original>R</original>
<variation>C</variation>
<location>
<position position="1294"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11243731." id="VAR_018786">
<original>P</original>
<variation>L</variation>
<location>
<position position="1331"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs543573." id="VAR_018787" evidence="16 21">
<original>I</original>
<variation>V</variation>
<location>
<position position="1386"/>
</location>
</feature>
<feature type="sequence variant" description="In ALS4; dbSNP:rs112089123." id="VAR_071685" evidence="24">
<original>C</original>
<variation>G</variation>
<location>
<position position="1554"/>
</location>
</feature>
<feature type="sequence variant" description="In SCAR1; heterozygous in a British family; dbSNP:rs762175796." id="VAR_018788" evidence="14">
<original>F</original>
<variation>S</variation>
<location>
<position position="1756"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2296871." id="VAR_018789" evidence="16">
<original>T</original>
<variation>A</variation>
<location>
<position position="1855"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2296871." id="VAR_059458">
<original>T</original>
<variation>P</variation>
<location>
<position position="1855"/>
</location>
</feature>
<feature type="sequence variant" description="In SCAR1; dbSNP:rs121434379." id="VAR_072588" evidence="28">
<original>L</original>
<variation>R</variation>
<location>
<position position="1976"/>
</location>
</feature>
<feature type="sequence variant" description="In ALS4; dbSNP:rs746525639." id="VAR_071686" evidence="24">
<original>K</original>
<variation>E</variation>
<location>
<position position="2029"/>
</location>
</feature>
<feature type="sequence variant" description="In ALS4; dbSNP:rs121434378." id="VAR_018790" evidence="15">
<original>R</original>
<variation>H</variation>
<location>
<position position="2136"/>
</location>
</feature>
<feature type="sequence variant" description="In SCAR1; dbSNP:rs28940290." id="VAR_018791" evidence="14">
<original>P</original>
<variation>L</variation>
<location>
<position position="2213"/>
</location>
</feature>
<feature type="sequence variant" description="In SCAR1." id="VAR_071687" evidence="30">
<original>M</original>
<variation>T</variation>
<location>
<position position="2229"/>
</location>
</feature>
<feature type="sequence variant" description="In SCAR1." id="VAR_036650" evidence="17">
<original>P</original>
<variation>R</variation>
<location>
<position position="2368"/>
</location>
</feature>
<feature type="sequence variant" description="In ALS4; dbSNP:rs151117904." id="VAR_071688" evidence="24">
<original>I</original>
<variation>T</variation>
<location>
<position position="2547"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1056899." id="VAR_018792" evidence="13 16 21">
<original>I</original>
<variation>V</variation>
<location>
<position position="2587"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3739927." id="VAR_018793" evidence="16">
<original>S</original>
<variation>G</variation>
<location>
<position position="2612"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with EXOSC9 and UBE2I and decreases sumoylation." evidence="31">
<original>E</original>
<variation>K</variation>
<location>
<position position="65"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAD98045." ref="2" evidence="36">
<original>L</original>
<variation>S</variation>
<location>
<position position="657"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAD97857." ref="2" evidence="36">
<original>E</original>
<variation>G</variation>
<location>
<position position="866"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAH18105." ref="2" evidence="36">
<original>K</original>
<variation>E</variation>
<location>
<position position="894"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAD98045 and 5; BAA31600." ref="2 5" evidence="36">
<original>E</original>
<variation>G</variation>
<location>
<position position="895"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAD97857." ref="2" evidence="36">
<original>P</original>
<variation>T</variation>
<location>
<position position="977"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAD97857." ref="2" evidence="36">
<original>F</original>
<variation>C</variation>
<location>
<position position="1073"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAA31600." ref="5" evidence="36">
<original>Q</original>
<variation>E</variation>
<location>
<position position="1276"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAH18105." ref="2" evidence="36">
<original>R</original>
<variation>G</variation>
<location>
<position position="1593"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAD97857." ref="2" evidence="36">
<original>N</original>
<variation>K</variation>
<location>
<position position="1626"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAH18105." ref="2" evidence="36">
<original>I</original>
<variation>V</variation>
<location>
<position position="1634"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAH32622." ref="4" evidence="36">
<original>PVG</original>
<variation>TRP</variation>
<location>
<begin position="1648"/>
<end position="1650"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAD97857." ref="2" evidence="36">
<original>L</original>
<variation>P</variation>
<location>
<position position="1725"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAD98045 and 4; AAH32600/AAH32622." ref="2 4" evidence="36">
<original>E</original>
<variation>K</variation>
<location>
<position position="1826"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAR13367 and 4; AAH32622." ref="1 4" evidence="36">
<original>F</original>
<variation>L</variation>
<location>
<position position="1867"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAD97857." ref="2" evidence="36">
<original>Q</original>
<variation>L</variation>
<location>
<position position="2078"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; BAB14299." ref="6" evidence="36">
<original>M</original>
<variation>E</variation>
<location>
<position position="2324"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAH18105." ref="2" evidence="36">
<original>G</original>
<variation>E</variation>
<location>
<position position="2423"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAH18105." ref="2" evidence="36">
<original>D</original>
<variation>G</variation>
<location>
<position position="2458"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAD97857." ref="2" evidence="36">
<original>P</original>
<variation>S</variation>
<location>
<position position="2539"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAD97857." ref="2" evidence="36">
<original>H</original>
<variation>R</variation>
<location>
<position position="2565"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; BAB14299." ref="6" evidence="36">
<original>F</original>
<variation>L</variation>
<location>
<position position="2577"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="A2AKX3"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255"/>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14770181"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15106121"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16644229"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16717225"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17096168"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17562789"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17974005"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19515850"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21112256"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21190393"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21576111"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21700224"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23149945"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23566282"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23786967"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23941260"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24105744"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24244371"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26700805"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14770181"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="17974005"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000305"/>
<evidence key="37" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:445"/>
</source>
</evidence>
<sequence length="2677" mass="302880" checksum="552FFE4A23A83868" modified="2010-05-18" version="4">
MSTCCWCTPGGASTIDFLKRYASNTPSGEFQTADEDLCYCLECVAEYHKARDELPFLHEV
LWELETLRLINHFEKSMKAEIGDDDELYIVDNNGEMPLFDITGQDFENKLRVPLLEILKY
PYLLLHERVNELCVEALCRMEQANCSFQVFDKHPGIYLFLVHPNEMVRRWAILTARNLGK
VDRDDYYDLQEVLLCLFKVIELGLLESPDIYTSSVLEKGKLILLPSHMYDTTNYKSYWLG
ICMLLTILEEQAMDSLLLGSDKQNDFMQSILHTMEREADDDSVDPFWPALHCFMVILDRL
GSKVWGQLMDPIVAFQTIINNASYNREIRHIRNSSVRTKLEPESYLDDMVTCSQIVYNYN
PEKTKKDSGWRTAICPDYCPNMYEEMETLASVLQSDIGQDMRVHNSTFLWFIPFVQSLMD
LKDLGVAYIAQVVNHLYSEVKEVLNQTDAVCDKVTEFFLLILVSVIELHRNKKCLHLLWV
SSQQWVEAVVKCAKLPTTAFTRSSEKSSGNCSKGTAMISSLSLHSMPSNSVQLAYVQLIR
SLLKEGYQLGQQSLCKRFWDKLNLFLRGNLSLGWQLTSQETHELQSCLKQIIRNIKFKAP
PCNTFVDLTSACKISPASYNKEESEQMGKTSRKDMHCLEASSPTFSKEPMKVQDSVLIKA
DNTIEGDNNEQNYIKDVKLEDHLLAGSCLKQSSKNIFTERAEDQIKISTRKQKSVKEISS
YTPKDCTSRNGPERGCDRGIIVSTRLLTDSSTDALEKVSTSNEDFSLKDDALAKTSKRKT
KVQKDEICAKLSHVIKKQHRKSTLVDNTINLDENLTVSNIESFYSRKDTGVQKGDGFIHN
LSLDPSGVLDDKNGEQKSQNNVLPKEKQLKNEELVIFSFHENNCKIQEFHVDGKELIPFT
EMTNASEKKSSPFKDLMTVPESRDEEMSNSTSVIYSNLTREQAPDISPKSDTLTDSQIDR
DLHKLSLLAQASVITFPSDSPQNSSQLQRKVKEDKRCFTANQNNVGDTSRGQVIIISDSD
DDDDERILSLEKLTKQDKICLEREHPEQHVSTVNSKEEKNPVKEEKTETLFQFEESDSQC
FEFESSSEVFSVWQDHPDDNNSVQDGEKKCLAPIANTTNGQGCTDYVSEVVKKGAEGIEE
HTRPRSISVEEFCEIEVKKPKRKRSEKPMAEDPVRPSSSVRNEGQSDTNKRDLVGNDFKS
IDRRTSTPNSRIQRATTVSQKKSSKLCTCTEPIRKVPVSKTPKKTHSDAKKGQNRSSNYL
SCRTTPAIVPPKKFRQCPEPTSTAEKLGLKKGPRKAYELSQRSLDYVAQLRDHGKTVGVV
DTRKKTKLISPQNLSVRNNKKLLTSQELQMQRQIRPKSQKNRRRLSDCESTDVKRAGSHT
AQNSDIFVPESDRSDYNCTGGTEVLANSNRKQLIKCMPSEPETIKAKHGSPATDDACPLN
QCDSVVLNGTVPTNEVIVSTSEDPLGGGDPTARHIEMAALKEGEPDSSSDAEEDNLFLTQ
NDPEDMDLCSQMENDNYKLIELIHGKDTVEVEEDSVSRPQLESLSGTKCKYKDCLETTKN
QGEYCPKHSEVKAADEDVFRKPGLPPPASKPLRPTTKIFSSKSTSRIAGLSKSLETSSAL
SPSLKNKSKGIQSILKVPQPVPLIAQKPVGEMKNSCNVLHPQSPNNSNRQGCKVPFGESK
YFPSSSPVNILLSSQSVSDTFVKEVLKWKYEMFLNFGQCGPPASLCQSISRPVPVRFHNY
GDYFNVFFPLMVLNTFETVAQEWLNSPNRENFYQLQVRKFPADYIKYWEFAVYLEECELA
KQLYPKENDLVFLAPERINEEKKDTERNDIQDLHEYHSGYVHKFRRTSVMRNGKTECYLS
IQTQENFPANLNELVNCIVISSLVTTQRKLKAMSLLGSRNQLARAVLNPNPMDFCTKDLL
TTTSERIIAYLRDFNEDQKKAIETAYAMVKHSPSVAKICLIHGPPGTGKSKTIVGLLYRL
LTENQRKGHSDENSNAKIKQNRVLVCAPSNAAVDELMKKIILEFKEKCKDKKNPLGNCGD
INLVRLGPEKSINSEVLKFSLDSQVNHRMKKELPSHVQAMHKRKEFLDYQLDELSRQRAL
CRGGREIQRQELDENISKVSKERQELASKIKEVQGRPQKTQSIIILESHIICCTLSTSGG
LLLESAFRGQGGVPFSCVIVDEAGQSCEIETLTPLIHRCNKLILVGDPKQLPPTVISMKA
QEYGYDQSMMARFCRLLEENVEHNMISRLPILQLTVQYRMHPDICLFPSNYVYNRNLKTN
RQTEAIRCSSDWPFQPYLVFDVGDGSERRDNDSYINVQEIKLVMEIIKLIKDKRKDVSFR
NIGIITHYKAQKTMIQKDLDKEFDRKGPAEVDTVDAFQGRQKDCVIVTCVRANSIQGSIG
FLASLQRLNVTITRAKYSLFILGHLRTLMENQHWNQLIQDAQKRGAIIKTCDKNYRHDAV
KILKLKPVLQRSLTHPPTIAPEGSRPQGGLPSSKLDSGFAKTSVAASLYHTPSDSKEITL
TVTSKDPERPPVHDQLQDPRLLKRMGIEVKGGIFLWDPQPSSPQHPGATPPTGEPGFPVV
HQDLSHIQQPAAVVAALSSHKPPVRGEPPAASPEASTCQSKCDDPEEELCHRREARAFSE
GEQEKCGSETHHTRRNSRWDKRTLEQEDSSSKKRKLL
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>